These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34469737)

  • 1. Transcriptional control of brain tumor stem cells by a carbohydrate binding protein.
    Sharanek A; Burban A; Hernandez-Corchado A; Madrigal A; Fatakdawala I; Najafabadi HS; Soleimani VD; Jahani-Asl A
    Cell Rep; 2021 Aug; 36(9):109647. PubMed ID: 34469737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
    Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
    Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OSMR controls glioma stem cell respiration and confers resistance of glioblastoma to ionizing radiation.
    Sharanek A; Burban A; Laaper M; Heckel E; Joyal JS; Soleimani VD; Jahani-Asl A
    Nat Commun; 2020 Aug; 11(1):4116. PubMed ID: 32807793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
    Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
    Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGFR Activates a TAZ-Driven Oncogenic Program in Glioblastoma.
    Gao M; Fu Y; Zhou W; Gui G; Lal B; Li Y; Xia S; Ji H; Eberhart CG; Laterra J; Ying M
    Cancer Res; 2021 Jul; 81(13):3580-3592. PubMed ID: 33910930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of glioblastoma tumorigenesis by feed-forward cytokine signaling.
    Jahani-Asl A; Yin H; Soleimani VD; Haque T; Luchman HA; Chang NC; Sincennes MC; Puram SV; Scott AM; Lorimer IA; Perkins TJ; Ligon KL; Weiss S; Rudnicki MA; Bonni A
    Nat Neurosci; 2016 Jun; 19(6):798-806. PubMed ID: 27110918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 3A mediated brain tumor stem cell proliferation and invasion in EGFRviii mutant gliomas.
    Higgins DMO; Caliva M; Schroeder M; Carlson B; Upadhyayula PS; Milligan BD; Cheshier SH; Weissman IL; Sarkaria JN; Meyer FB; Henley JR
    BMC Cancer; 2020 Dec; 20(1):1213. PubMed ID: 33302912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
    Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
    J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation by EZH2 activates STAT3 in glioblastoma.
    Cancer Discov; 2013 Jul; 3(7):OF21. PubMed ID: 23847365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
    Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
    J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Significance of low mTORC1 activity in defining the characteristics of brain tumor stem cells.
    Han YP; Enomoto A; Shiraki Y; Wang SQ; Wang X; Toyokuni S; Asai N; Ushida K; Ara H; Ohka F; Wakabayashi T; Ma J; Natsume A; Takahashi M
    Neuro Oncol; 2017 May; 19(5):636-647. PubMed ID: 28453744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic inhibition of tumor growth by combination treatment with drugs against different subpopulations of glioblastoma cells.
    Chang CH; Liu WT; Hung HC; Gean CY; Tsai HM; Su CL; Gean PW
    BMC Cancer; 2017 Dec; 17(1):905. PubMed ID: 29284440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAF promotes stemness and radioresistance of glioma stem cells.
    Ong DST; Hu B; Ho YW; Sauvé CG; Bristow CA; Wang Q; Multani AS; Chen P; Nezi L; Jiang S; Gorman CE; Monasterio MM; Koul D; Marchesini M; Colla S; Jin EJ; Sulman EP; Spring DJ; Yung WA; Verhaak RGW; Chin L; Wang YA; DePinho RA
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9086-E9095. PubMed ID: 29073105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.